The valuation premium suggests investors are pricing in the company's ability to consistently deploy capital into regulated assets, effectively treating the stock as a high-quality bond proxy. However, the forward PEG ratio of 2.77 warrants caution, as it implies that current growth expectations may be fully baked into the price, leaving little room for regulatory disappointment.

This persistent gap between earned and allowed returns appears to be a direct consequence of regulatory lag, where the timing of rate case approvals fails to keep pace with the rapid acceleration of capital expenditures. Investors should monitor whether future rate filings can effectively bridge this delta or if inflationary pressures will continue to suppress profitability.

The interest coverage ratio, which dipped as low as 1.77 in 2025Q4, suggests that the company's financial flexibility may be tightening as debt loads increase. This leverage profile implies that any sustained rise in interest rates could disproportionately impact future earnings growth by increasing the cost of servicing the debt required for ongoing capital projects.

While the dividend is currently supported by operating cash flow, the high payout ratio in the context of a capital-intensive business model suggests a potential future reliance on dilutive equity offerings. This dynamic creates a tension between maintaining shareholder yield and funding the necessary rate base expansion required for long-term growth.